#Veterinary Oncology Market Share

[industrynewsupdates]

Veterinary Oncology Market Size, Share And Trends Analysis Report

The global veterinary oncology market size is expected to reach USD 3.11 billion in 2030 and is projected to grow at a CAGR of 12.08% from 2025 to 2030. Increasing prevalence of cancer in pets and demand for veterinary diagnostics are projected to drive the market over the forecast period.

Adoption of canine cancer registry globally to estimate cancer incidences is another driving factor for the market growth. According to frontiers in Veterinary Science in February 2019, the Swiss Canine Cancer Registry (SCCR) was used as a data source and was compiled for future comparative studies of canine and human cancers. This database is further helpful in mitigating the incidence of malignant tumors in the human population, thereby driving the market growth.

Researchers carrying out studies focused on veterinary oncology are further boosting the veterinary oncology market growth. For instance, University of Illinois in August 2017, carried out study that involves more precise detection of metastasis (spread of cancer through the body) for head and neck tumors in dogs. Moreover, the market players are also focusing on new product innovation and strategic collaborations. For instance, in 2018 AdvaVet, a subsidiary of Oasmia Pharmaceutical AB, developed XR17 technology, which is nanoparticle formulation based that makes a single Active Pharmaceutical Ingredient (API) or multiple APIs water soluble. It is a combination therapy and is also a standard treatment for a number of cancer diseases in pet animals. 

Gather more insights about the market drivers, restrains and growth of the Veterinary Oncology Market

Veterinary Oncology Market Report Highlights

• Increasing prevalence of cancer in companion animals, several clinical trial studies to evaluate the safety and effectiveness of cancer therapeutics for pets and technological advancements in veterinary oncology treatment are anticipated to create growth opportunities in the market.

• Chemotherapy accounted for the largest revenue share over the coming years, owing to its increasing adoption for pet cancer treatment either alone or in combination with other therapies.

• The canine segment held the largest revenue share of over 86.09% in 2024, increasing the population of dogs and high prevalence of cancer in dogs as compared to cats.

• North America held the dominant share as of 2024, due to the favorable government policies, new product launch by the companies, and huge investment for veterinary oncology treatment.

• Asia Pacific is anticipated to witness lucrative growth due to increasing focus on animal health and expenditure, increasing number of pet population being exposed to cancer, government focus on animal safety, and several initiatives to curb cancer cases in pet animals.

Veterinary Oncology Market Segmentation

Grand View Research has segmented the global Veterinary Oncology market report based on product, type of waste, end use, and region:

Veterinary Oncology Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

• Canine

• Feline

• Equine

Veterinary Oncology Therapy Outlook (Revenue, USD Million, 2018 - 2030)

• Radiotherapy 

o Stereotactic Radiation Therapy

o LINAC

o Other Types

o Conventional Radiation Therapy

o Surgery

o Chemotherapy

o Immunotherapy

o Other Therapies

Veterinary Oncology Cancer Type Outlook (Revenue, USD Million, 2018 - 2030)

• Skin Cancers

• Lymphomas

• Sarcomas

• Others

Veterinary Oncology Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

o Mexico

• Europe

o UK

o Germany

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

o Rest of EU

• Asia Pacific

o Japan

o China

o India

o Australia

o South Korea

o Thailand

o Rest of APAC

• Latin America

o Brazil

o Argentina

o Rest of LA

• Middle East and Africa

o South Africa

o Saudi Arabia

o UAE

o Kuwait

o Rest of MEA

Order a free sample PDF of the Veterinary Oncology Market Intelligence Study, published by Grand View Research.

[dtgmarketreport]

Pet Pharmaceuticals Market Size, Share & Forecast 2025-2035

Industry Outlook for the Pet Pharmaceuticals Market

The pet pharmaceuticals market is witnessing significant growth, driven by increasing pet ownership and heightened awareness of animal health and wellness. Valued at USD 13.2 billion in 2024, the market is projected to reach USD 30.3 billion by 2035, growing at a CAGR of 7.85% between 2025 and 2035. This growth reflects the broader commitment of pet owners and the industry to enhancing the quality of life for companion animals.

Key Market Dynamics

Growing Pet Ownership and Awareness

The rise in global pet ownership has significantly boosted the demand for veterinary care and pharmaceuticals. Pet owners today are more invested in preventive healthcare, mirroring trends in human health. This has led to the development and adoption of advanced veterinary medicines and treatments.

Innovations in Veterinary Medicine

Advancements in veterinary science, including genetic testing and personalized medicine, are driving the market forward. Customized treatments based on genetic predispositions are becoming more prevalent, offering targeted care for specific pet needs. For example, over 60% of pet owners in the U.S. now seek personalized healthcare solutions for their animals.

Expansion of Online Pharmacies

The rise of e-commerce and online veterinary pharmacies has made pet medications more accessible. This shift has also enabled faster consultations through telemedicine, improving diagnosis and treatment timelines. Pharmaceutical companies are leveraging this trend to reach a digitally savvy customer base.

Challenges in Cost and Accessibility

Despite its growth, the market faces barriers in the form of high veterinary care costs. Routine check-ups, medications, and specialized treatments often prove expensive, deterring some pet owners from seeking necessary care. This financial strain underscores the need for affordable healthcare solutions.

Request sectional data : https://www.metatechinsights.com/industry-insights/pet-pharmaceuticals-market-1173

Segment Analysis

By Pet Type

Dogs dominate the market due to their higher ownership rates and susceptibility to various illnesses. This drives demand for anti-infectives, pain relievers, and other medications.

Other segments, including cats and small animals, are growing steadily as awareness of their health needs increases.

By Product Type

Anti-infectives lead the market, addressing a wide range of infections.

Vaccines, anti-inflammatory drugs, and parasiticides also hold significant market shares as preventive care gains traction.

By Therapeutic Area

Oncology is an emerging segment due to the increasing prevalence of cancer in pets. Advanced therapies like immunotherapy and targeted treatments are gaining momentum.

Dermatology and orthopedic care are also key areas, driven by conditions such as arthritis and skin disorders in aging pets.

By Route of Administration

Medications are available in diverse formats, including oral, injectable, and topical options, catering to different pet needs and owner preferences.

By Distribution Channel

Veterinary hospitals and clinics remain the primary distribution channels.

However, online pharmacies are rapidly growing, offering convenience and affordability.

Regional Insights

North America

North America is the largest market, driven by high pet ownership and substantial spending on pet healthcare.

The U.S. leads in innovation, with robust regulatory support for drug approvals and the growth of e-commerce platforms.

Asia Pacific

The Asia Pacific is the fastest-growing market, fueled by rising disposable incomes and urbanization. Countries like China and India are seeing a surge in pet ownership, while Australia and New Zealand maintain steady growth due to established veterinary practices.

Regulatory challenges and price sensitivity persist, but overall trends are promising.

Europe

Europe shows steady growth, with countries like Germany, France, and the U.K. investing in advanced veterinary care.

Latin America and the Middle East & Africa

These regions are growing as awareness of pet health increases. The expansion of e-commerce is helping improve access to veterinary products.

Opportunities and Challenges

Opportunities

1. Personalized Medications

Tailored treatments for specific breeds or diseases offer a lucrative growth avenue. These solutions enhance treatment effectiveness and improve owner satisfaction.

2.Telemedicine Growth

Veterinary telehealth is bridging the gap between pet owners and professionals, enabling faster consultations and online prescription fulfillment.

3.Preventive Care

The emphasis on vaccines and parasite control presents opportunities for growth in preventive healthcare segments.

4.Challenges

1.High Costs

Expensive treatments and medications pose barriers, especially in regions with limited access to pet insurance.

2.Regulatory Hurdles

Varying regulations across regions can slow down drug approvals and market entry for new players.

Competitive Landscape

The market is highly competitive, with major players like Zoetis, Merck Animal Health, Boehringer Ingelheim, and Elanco Animal Health leading innovation. These companies invest heavily in R&D to introduce new products, such as the Zenrelia™ tablets launched by Elanco in 2024 for canine dermatology.

Key Players

Zoetis: Known for its broad product range, including vaccines and anti-infectives.

Elanco Animal Health: Focuses on innovative solutions for dermatology and parasiticides.

Virbac and PetIQ: Emerging players emphasizing accessible healthcare.

High-value mergers and acquisitions characterize the market, enabling companies to expand their offerings and stay competitive.

Recent Developments

1.FDA Approvals

Regulatory approvals for advanced treatments like Zenrelia™ are shaping the market.

2.E-commerce Expansion

Companies are leveraging online platforms to reach a broader audience, especially in emerging markets.

Conclusion

The pet pharmaceuticals market is poised for robust growth, driven by rising pet owPet Pharmaceuticals Market Size, Share & Forecast 2025-2035nership, technological advancements, and increased spending on veterinary care. While challenges like high costs persist, opportunities in personalized medicine and telehealth are paving the way for innovation. With major players leading the charge, the industry is set to transform how pet healthcare is delivered, ensuring a brighter future for pets worldwide. Get sample report https://www.metatechinsights.com/request-sample/1173  for more deatiled insights

[harsh24mr]

Veterinary Stereotactic Radiosurgery System Market, Global Outlook and Forecast 2024-2030

The global Veterinary Stereotactic Radiosurgery System market was valued at US$ 17.67 million in 2023 and is projected to reach US$ 29.35 million by 2030, at a CAGR of 7.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Radioactive medical equipment for animals can send high-dose radiation focused on a small and precise area.

Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-veterinary-stereotactic-radiosurgery-system-forecast-2024-2030-658

Report Sample includes:

Table of Contents

List of Tables & Figures

Charts

Research Methodology

This report aims to provide a comprehensive presentation of the global market for Veterinary Stereotactic Radiosurgery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Stereotactic Radiosurgery System. This report contains market size and forecasts of Veterinary Stereotactic Radiosurgery System in global, including the following market information: Global Veterinary Stereotactic Radiosurgery System Market Revenue, 2019-2024, 2025-2030, ($ millions) Global Veterinary Stereotactic Radiosurgery System Market Sales, 2019-2024, 2025-2030, (K Units) Global top five Veterinary Stereotactic Radiosurgery System companies in 2023 (%) The US Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million. Gamma Knife Segment to Reach $ Million by 2030, with a % CAGR in the next six years.

The global key manufacturers of Veterinary Stereotactic Radiosurgery System include PetCure Oncology, Varian Medical Systems, Accuray and Elekta AB, etc. in 2023, the global top five players have a share approximately % in terms of revenue.

We surveyed the Veterinary Stereotactic Radiosurgery System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment: Global Veterinary Stereotactic Radiosurgery System Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units) Global Veterinary Stereotactic Radiosurgery System Market Segment Percentages, by Type, 2023 (%) Gamma Knife PBRT Cyber Knife Global Veterinary Stereotactic Radiosurgery System Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units) Global Veterinary Stereotactic Radiosurgery System Market Segment Percentages, by Application, 2023 (%) Animal Hospital Research center other Global Veterinary Stereotactic Radiosurgery System Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units) Global Veterinary Stereotactic Radiosurgery System Market Segment Percentages, By Region and Country, 2023 (%) North America (United States, Canada, Mexico) Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe) Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC) The Middle East and Africa (Middle East, Africa) South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis The report also provides analysis of leading market participants including: Key companies Veterinary Stereotactic Radiosurgery System revenues in global market, 2019-2024 (Estimated), ($ millions) Key companies Veterinary Stereotactic Radiosurgery System revenues share in global market, 2023 (%) Key companies Veterinary Stereotactic Radiosurgery System sales in global market, 2019-2024 (Estimated), (K Units) Key companies Veterinary Stereotactic Radiosurgery System sales share in global market, 2023 (%) Further, the report presents profiles of competitors in the market, key players include: PetCure Oncology Varian Medical Systems Accuray Elekta AB Outline of Major Chapters: Chapter 1: Introduces the definition of Veterinary Stereotactic Radiosurgery System, market overview. Chapter 2: Global Veterinary Stereotactic Radiosurgery System market size in revenue and volume. Chapter 3: Detailed analysis of Veterinary Stereotactic Radiosurgery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Veterinary Stereotactic Radiosurgery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Global Veterinary Stereotactic Radiosurgery System capacity by region & country. Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 11: The main points and conclusions of the report.

Get the Complete Report & TOC at https://www.24marketreports.com/lif…ic-radiosurgery-system-forecast-2024-2030-658 CONTACT US: 276 5th Avenue, New York , NY 10001,United States International: (+1) 646 781 7170 Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports

Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-veterinary-stereotactic-radiosurgery-system-forecast-2024-2030-658

[market-insider]

Veterinary Clinical Trials Market Future Outlook: Analyzing Size, Share, and Growth Patterns

The global veterinary clinical trials market size is expected to reach USD 8.99 billion by 2030, exhibiting a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. The key factors driving industry growth include increased R&D expenditure by key players, rising prevalence of chronic diseases in animals, advancements in veterinary medicines, and rise in strategic alliances. For instance, in April 2024, Boehringer Ingelheim, a biopharmaceutical company focused on both human and animal health invested USD 593.5 Mn in animal health R&D to accelerate veterinary clinical trials as well as to develop innovative veterinary medicine.

Veterinary Clinical Trials Market Report Highlights

Ongoing advancements in veterinary medicine drive the demand for veterinary clinical trials to improve animal health and welfare. Additionally, growing R&D investments by key players to innovate veterinary medicine are expected to boost market demand.

By animal type,companion animal segment dominated the market in 2023 and is projected to witness the fastest growth rate of 9.5% in the coming years. Furthermore, among companion animals, canines segment is holding highest market share in 2023.

In terms of indication, oncology segment dominated the market with a share of 27.51% in 2023, owing to the rising prevalence of cancers in animals and growing R&D investment for veterinary oncology. Whereas internal medicine segment is expected to grow at the fastest rate of over 10.2% in the coming years.

Based on the sponsor, pharmaceutical and biopharmaceutical companies segment dominated the market in 2023, and the academics and research centers segment is expected to grow at the fastest rate of over 9.8% in the coming years.

Medicines accounted for the largest market share by intervention type in 2023. However, medical device segment is estimated to witness the highest growth rate of around 10.0% in the near future.

In 2023, North America held the highest share of 33.70% of the market by region.The Asia Pacific region is expected to grow at the fastest rate of over 10.1% in the coming years.

For More Details or Sample Copy please visit link @: Veterinary Clinical Trials Market Report

Additionally, an increasing number of clinical trials for rare diseases in pets is expected to drive veterinary clinical trial market. Veterinary clinics and research institutions are undertaking specialized clinical trial initiatives focused specifically on rare canine cancers. These trials aim to investigate novel treatment approaches, including targeted therapies, immunotherapies, and precision medicine techniques designed for individual dogs' genetic profiles. For instance, in March 2024, Vivesto AB initiated its Paccal Vet clinical trial for dogs with splenic hemangiosarcoma, marking a significant step toward addressing this challenging cancer type in canines. The trial aims to assess the safety and efficacy of Paccal Vet, formulated with XR-17 technology, with promising results potentially leading to further pivotal studies.

There is a growing focus on preventive care in veterinary medicine. Clinical trials aimed at developing preventive treatments, such as vaccines and early diagnostic tools, are becoming more common. Furthermore, veterinary clinics and research institutions are launching specialized clinical trial initiatives focused specifically on rare canine cancers. These trials aim to investigate novel treatment approaches, including targeted therapies, immunotherapies, and precision medicine techniques tailored to individual dogs' genetic profiles.

List of Key Players in the Veterinary Clinical Trials Market

Charles River Laboratory

IDEXX Laboratories, Inc.

Boehringer Ingelheim International GmbH.

Argenta

Bioagile Therapeutics Pvt. Ltd.

Veterinary Research Management

Merck & Co., Inc.

Labcorp Drug Development

OCR - Oncovet Clinical Research

Vivesto AB

Vetbiolix

[trendingreportz]

DNA Vaccines Market - Forecast(2024 - 2030)

 DNA Vaccines Market is forecast to reach revenue of $9.43 Billion by 2025, growing at a CAGR of 33.86% during the forecast period 2020-2025. DNA vaccines are composed of deoxyribonucleic acid, which encodes antigens and stimulates a wider range of immune responses in the body with few side effects. DNA based Vaccines concept deliver to cells after which the gene is expressed and can generate the protein of interest. Clinical trials of some DNA vaccines have shown promising results in the treatment of several types of cancers like metastatic melanoma, prostate carcinoma, pancreatic cancer, and other solid tumors. The demand for DNA Vaccines is experiencing rapid growth owing to factors such as adoption of DNA Vaccines in Healthcare, Low cost, Increasing Technology, fewer side effects, increasing awareness about Health professionals and others. With the rise of COVID-19 pandemic throughout the world 

Request Sample

Key Takeaways

North America dominates the DNA Vaccines Market owing to the increasing prevalence of infectious diseases in countries such as U.S and Canada.

Adoption of DNA Vaccines in Healthcare, Low cost, Increasing Technology, fewer side effects, increasing awareness about Health professionals are some of the key factors which are leading the demand for DNA Vaccines.

With the current COVID-19 Outbreak there is a huge demand for vaccination that can hack to build better immunity in order to fight the virus

Detailed analysis of the Strength, Weakness, and opportunities of the prominent players operating in the market will be provided in the DNA Vaccines Market.

By Type – Segment Analysis 

Based on the types, the DNA Vaccines Market is segmented into Human DNA Vaccines and Animal DNA Vaccines. Animal DNA vaccine is dominating the market in 2019 and is estimated to grow at a CAGR of 19.8% during the forecast period 2020-2025. This is owing to the unavailability of human DNA vaccines in the market along with the rising incidence of canine melanoma and other animal diseases. Animal vaccines are third generation vaccines and contain DNA that codes for specific proteins from a pathogen. This DNA is injected into host body and produces protein for which the body generates immune response. Moreover, the strong pipeline of human targeted vaccines is likely to aid in the market growth

Inquiry Before Buying

By Application – Segment Analysis

Based on the applications, DNA Vaccines Market is segmented into Human Diseases which includes applications in Oncology, Infectious Disease, Allergies, and Veterinary Disease. The Veterinary Disease based on application is forecast to grow at a higher CAGR during the forecast period 2020-2025 owing to availability of DNA vaccines for animal diseases that includes canine melanoma vaccine (DOG), West Nile Innovator (Horse), Life tide-SW5 (Swine and other food animals) and Apex-IHN (Salmon fish). 

By Geography – Segment Analysis

Based on the geography the DNA Vaccines Market has covered globally viz North America, South America, Europe, Asia Pacific (APAC) and Rest of World (ROW). The Market in North America accounts for 43.7% of the total market share, which is attributed by government initiatives to immune citizens, coupled with high awareness regarding the benefits of genetic vaccines targeted towards animals. 

Asia Pacific region is set to be the highest growth during the forecast period 2020-2025 owing to rising awareness of people regarding the advantages of immunization against HPV and Hepatitis B. Additionally, it is estimated that the DNA Vaccines Market is set to grow exponentially during the forecast period 2020-2025 owing to COVID-19 outbreak.

Schedule a Call

Market Drivers - DNA Vaccines Market

Rising Demand for effective treatment of infectious disease in driving market

DNA Vaccines used to kill and stop the growth of microorganisms. These drugs can act as a defense system for the human body and neutralize the action of disease causative agents. With increasing research activities and Increasing awareness and extensive R&D drugs, there is rising demand for treatment of infectious diseases

Challenges - DNA Vaccines Market

The main area of uncertainty is related to the immunological impact, tissue distribution and persistence after injection and whether the DNA vaccine can leak into the environment. This, in turn, create a challenging point for the growth of DNA Vaccine. Also, with, the limited efficiency of plasmid-based techniques precluded their use in the creation of more accurate human cell models is one of the challenges for DNA Vaccine Market

Buy Now

Vitamin & Mineral Industry Outlook

Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the DNA Vaccines Market. In 2019, DNA Vaccines Market share is consolidated by the top ten players present in the market. DNA Vaccines Market Top 10 companies include Inovio Biomedical Corp, Merck & Co., Mitsubishi Tanabe, Dendreon Corporation, ASTELLAS PHARMA, Dynavax Technologies, Sanofi, Tekmira Pharmaceuticals GlaxoSmithKline Corp, Protein Sciences Corp.among others.

Acquisitions/Product Launches

In February 2020, Merck& Co announced the formation of a new, independent publicly-traded company focused on its Women’s Health, trusted Legacy Brands, and Biosimilars business. 

In February 2019, Merck & Co announced its acquisition of Immune Design Corp for nearly $300 million, gaining access to its immunotherapy programs.

[healthcaremarketanalysis]

Global Precision Medicine Market worth $50.2 billion by 2028

Precision Medicine Market in terms of revenue was estimated to be worth $29.1 billion in 2023 and is poised to reach $50.2 billion by 2028, growing at a CAGR of 11.5 % from 2023 to 2028 according to a new report by MarketsandMarkets™. The rising number of product approvals followed by growing focus on genetic testing, a prerequisite for precision medicine therapeutics, are the factors supporting market growth.

Download an Illustrative overview:

Browse in-depth TOC on "Precision Medicine Market"

189 - Tables

50 - Figures

240 – Pages

Hospitals and Clinics subsegment accounted is the fastest growing of the precision medicine market by product & service

Among the end user, the market is segmented hospitals and clinics and home care setting. In 2022, the hospitals and clinics segment accounted for the highest growth rate of the precision medicine market by end user. Growth in this market segment can be attributed to factors such as availability of better facilities and assistance in hospitals and clinics, accessibility to advanced diagnostic tests along with precise therapeutic regime among others.

Oncology is the fastest-growing segment of the precision medicine market by applications

Among the applications, the precision medicine market is segmented into drug discovery, clinical diagnostics, soil microbiome applications, industrial applications, ecological & environmental applications, veterinary applications, and other applications. In 2023, the drug discovery segment accounted for the fastest-growing share of the usage segment of precision medicine market. Growth in this market segment can be attributed to one of the major factors which is the growing number of research activities for development of new drugs.

Europe: The second-largest region in the precision medicine market.

The European market is the second-largest precision medicine market globally, mainly due to factors such as presence of key market players in the region. Europe is considered a major hub for precision medicine players and organizations. Moreover, greater awareness among people about newly emerging area of precision medicine, especially compared to developing regions.

Request Sample Pages:

Precision Medicine Market Dynamics:

Drivers:

Growth in genetic testing and companion diagnostics

Restraints:

High costs of therapeutics

Opportunities:

Growing demand for cell and gene therapies

Challenges:

Challenges associated with adoption of precision medicine

Key Market Players:

The market for precision medicine is competitive, with key players strategizing to capture the market. Prominent players in the precision medicine market are F. Hoffmann-La Roche Ltd. (Switzerland), Novartis AG (Switzerland), Bristol Myers Squibb (US), Gilead Sciences, Inc. (US), AstraZeneca (UK), Pfizer Inc. (US), AbbVie Inc. (US), Eli Lilly and Company (US), , GlaxoSmithKline plc (UK), Sanofi (France), Johnson & Johnson (US), Merck KGaA (Germany), Amgen, Inc. (US), Takeda Pharmaceutical Company Limited (Japan) among others.

Precision Medicine Market Advantages:

Personalized Treatment: Precision medicine tailors medical treatment and interventions to individual patients based on their genetic makeup, lifestyle, and specific health characteristics. This approach ensures that treatments are more effective, with fewer adverse effects, as they are customized to the patient's unique needs.

Improved Diagnostic Accuracy: Precision medicine relies on advanced diagnostic tools and genomic sequencing to identify diseases and their underlying causes with unparalleled accuracy. This leads to earlier and more precise diagnoses, enabling timely and targeted interventions.

Enhanced Drug Development: Pharmaceutical companies benefit from precision medicine by developing drugs that target specific genetic mutations or biomarkers associated with diseases. This approach streamlines drug development, reduces the likelihood of trial failures, and accelerates the availability of innovative treatments.

Reduced Healthcare Costs: By avoiding trial-and-error approaches to treatment and focusing on therapies that are more likely to work for a given patient, precision medicine can potentially lower healthcare costs in the long run. Fewer unnecessary treatments, hospitalizations, and adverse reactions contribute to cost savings.

Preventative Medicine: Precision medicine also emphasizes preventive strategies by identifying individuals at higher risk for certain diseases based on their genetic predispositions and lifestyle factors. This proactive approach allows for early interventions and lifestyle modifications to reduce disease risk.

Data-Driven Insights: The collection and analysis of extensive patient data, including genomic and clinical information, enable researchers to uncover new insights into disease mechanisms and treatment responses. This data-driven approach accelerates medical research and innovation.

Patient Empowerment: Precision medicine empowers patients by involving them in their healthcare decisions. Patients gain a better understanding of their health risks, treatment options, and potential outcomes, leading to more informed choices and improved overall healthcare experiences.

Tailored Therapies for Rare Diseases: Precision medicine is particularly advantageous for rare and orphan diseases, where traditional treatment options may be limited. By identifying specific genetic abnormalities associated with these conditions, researchers can develop targeted therapies that offer hope to patients who previously had few treatment options.

Global Health Impact: Precision medicine has the potential to address global health challenges by providing tailored solutions to diseases that affect diverse populations worldwide. It can facilitate the development of region-specific treatments and healthcare strategies.

Long-Term Healthcare Sustainability: As precision medicine advances, it contributes to the sustainability of healthcare systems by focusing resources on treatments that are most likely to be effective, reducing unnecessary healthcare expenditures, and improving overall health outcomes.

In summary, the precision medicine market holds the promise of revolutionizing healthcare by providing individualized, data-driven, and effective treatment options, ultimately benefiting patients, healthcare providers, pharmaceutical companies, and society at large.

Recent Developments:

In February 2023, Roche received EC approval for expansion of the Hemlibra (emicizumab) European Union (EU) marketing authorization.

In January 2022, AstraZeneca (UK) collaborated with Scorpion Therapeutics to develop and commercialize precision medicines against hard-to-target cancer proteins, with an aim to transform oncology treatment. The size of this deal accounted for USD 75 billion.

Content Source:

[research-blogs]

Veterinary Oncology Market Scale 2019 – 2027 Current Status and Trends by Company and Region

The global veterinary oncology market size is expected to reach USD 447.0 million by 2027, expanding at a CAGR of 10.7% over the forecast period, according to a new report by Grand View Research, Inc. Increasing prevalence of cancer in pets and demand for veterinary diagnostics are projected to drive the market over the forecast period.

Adoption of canine cancer registry globally to estimate cancer incidences is another driving factor for the market growth. According to frontiers in Veterinary Science in February 2019, the Swiss Canine Cancer Registry (SCCR) was used as a data source and was compiled for future comparative studies of canine and human cancers. This database is further helpful in mitigating the incidence of malignant tumors in the human population, thereby driving the market growth.

Researchers carrying out studies focused on veterinary oncology are further boosting the veterinary oncology market growth. For instance, University of Illinois in August 2017, carried out study that involves more precise detection of metastasis (spread of cancer through the body) for head and neck tumors in dogs. Moreover, the market players are also focusing on new product innovation and strategic collaborations. For instance, in 2018 AdvaVet, a subsidiary of Oasmia Pharmaceutical AB, developed XR17 technology, which is nanoparticle formulation based that makes a single Active Pharmaceutical Ingredient (API) or multiple APIs water soluble. It is a combination therapy and is also a standard treatment for a number of cancer diseases in pet animals.

View detailed insights @ https://bit.ly/3beiOXi

Veterinary Oncology Market Report Highlights

· Increasing prevalence of cancer in animals, clinical trial studies to evaluate safety and effectiveness of cancer therapeutics, and technological advancements in veterinary oncology treatment are anticipated to create growth opportunities in the market

· The chemotherapy segment is anticipated to account for the largest revenue share over the coming years owing to its increasing adoption either alone or in combination with other therapies

· The canine segment held the largest revenue in 2019 owing to increasing population of dogs and high prevalence of cancer in dogs as compared to cats

· Lymphoma dominated the market among other cancer types in 2019, due to high mortality rate in companion animals

· North America held the dominant share of the veterinary oncology market in 2019, due to favorable government policies, new product launches, and huge investment in oncology treatment

· Asia Pacific is anticipated to witness lucrative growth due to increasing focus on animal health and expenditure, increasing number of pets being exposed to cancer, and government focus on animal safety and initiatives to curb cancer in pet animals

· Some of the key companies are Boehringer Ingelheim; PetCure Oncology; Elanco; Accuray Incorporated; Varian Medical Systems; Zoetis; Karyopharm Therapeutics, Inc.; One Health; and Regeneus Ltd.

Get Sample PDF Copy @ https://bit.ly/3pU01JF

[bigfandeer]

Global Veterinary imaging Market Size By Vaccine Type, By Technology, By Geographic Scope And Forecast 2025

The global veterinary imaging market, as per the reports of Market Research Future (MRFR), can eye for an impressive CAGR of 7.14% over the review period (2016-2025). The time-span can also witness a surpassing of the predicted market valuation of USD 1800 million by the global veterinary imaging market. Veterinary imaging is the technology that provides a detailed report about diseases that pets or animals have. The global veterinary imaging market is all geared to profit much from advanced technologies that the market titans are launching.

Factors that can trigger market growth are cost-effective procedures, rising instances of pets getting covered by insurance policies, increasing disposable income, and surge in the ownership of pets across the world. Intensive animal farming can also impact the veterinary imaging market in the coming years.

Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2919

Market Segmentation:

By type, the global veterinary imaging market has been segmented into veterinary imaging instruments, veterinary imaging reagents, and veterinary imaging software.

By product type, the market for veterinary imaging is segmented into large animals, small companion animals, and others.

By therapeutic area, the global veterinary imaging market has been segmented into orthopedics and traumatology, cardiology, neurology, and, oncology.

By end-user, the market for veterinary imaging market is segmented into hospitals & clinics, and, academic institutes.

Regional Analysis

Europe, Asia Pacific (APAC), the Americas, and the Middle East & Africa (MEA) are region considered during the compilation of the global veterinary imaging market report.

The Americas accounted for the largest market share in 2018. It is predicted to exhibit 7.62% CAGR during the forecast period due to rise in pet ownership rates, demand for pet insurance, increase in veterinary expenditure. This is supported by statistics by the American Pet Products Association which stated nearly 68% of pet owners in the U.S. accounting for a pet in their household.

Europe is the second biggest region due to presence of veterinary clinics, advanced diagnostic procedures, and rise in pet ownership. On the other hand, the APAC region is driven by rise of nuclear families, large expendable income levels, and adoption of pets.

The MEA market can face a sluggish growth rate during the forecast period due to low production rate of purebreds and low investments by the pet care sector.

Competitive Landscape:

MRFR includes several companies that would influence the veterinary imaging market in the coming years. They are Hallmarq Veterinary Imaging Ltd, Esaote SpA, Diagnostic Imaging System, Inc, Heska Corporation, General Electric Canon Inc., Merry X-Ray, Medical Imaging / IMCO, Inc, Fujifilm Holding Corporation, Carestream Health, BCF Technology Ltd, and Idexx Laboratories Inc.

In 2019, Sound, a global leader in providing veterinary imaging solutions, teamed up with Canon for their digital radiography detectors and medical SDK. The result is a software, that would provide a seamless, robust, veterinary-specific digital radiography system.

List Of Tables

TABLE 1 MARKET SYNOPSIS 17

TABLE 2 LIST OF ASSUMPTIONS 19

TABLE 3 GLOBAL VETERINARY IMAGING MARKET BY PRODUCT TYPE, 2020-2027 (USD MILLION) 35

TABLE 4 GLOBAL VETERINARY IMAGING INSTRUMENTS MARKET BY REGION, 2020-2027 (USD MILLION) 36

TABLE 5 GLOBAL VETERINARY IMAGING INSTRUMENTS MARKET BY TYPE, 2020-2027 (USD MILLION) 36

Browse Complete Report @ https://www.marketresearchfuture.com/reports/veterinary-imaging-market-2919

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half- Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

[prwizard]

Global Healthcare and Wellness Awards 2022: Meet the Winners

Hypedge Media awarded healthcare professionals and hospitals nationwide during the 2022 edition of the Global Healthcare and Wellness Awards 2022. This was held on the 19th of November 2022 at the WelcomHotel by ITC, Chennai.

 The Chief Guest of the program was Padma Shri Dr. Vijay Kumar Shah, and the Guest of Honors was K. Pushpaleela (Ex-Minister, Women and Social Welfare Department ), Dr. R. Kannan (Chairman, Prime Indian Hospitals ), Prof. N. Balaji (Director & Trustee, Sri Narayani Hospital & Research Centre), Dr. C.J. Vetrievel (Director. - Be Well Hospitals), Sanjay Kumar Singh (Vice President, Sales Marketing

Rusan Pharma Ltd) and Gaurav Gautam (Founder of I CAN Foundation and CEO of Hypedge Media). They shared their wishes with all the selected awardees of GHWA 2022.

 Global Healthcare and Wellness Awards are conferred on the outstanding / highest achievers in International Healthcare Industry. This most awaited global platform is bringing eminent healthcare experts together from the health world to understand the health revolution, market dynamics, the impact of digital technologies on the masses, and the future of health & healthcare in India. The platform would also recognize and felicitate massive efforts of various health initiatives, healthcare professionals, hospitals, institutions, and initiatives benefiting India through a technology-enabled healthcare ecosystem.

  Here's the list of this Year's (2022) winners for the Global Healthcare and Wellness Awards:

 Dr. Sangita Motiram Gavit

Excellence in Medical Education

Dr Narendra Singh

Excellence Award in Cardiology

Dr. Manasi Wakankar

Award for Leadership And Management in Healthcare

James Aruldas Silvai

Medical Innovation & Leadership Award

Dr. Ekta Shrivastava

Healthcare Icon of the Year

Dr. KVNN Santosh Murthy

Excellence in Diabetic Foot & Burns Management

Dr. RANJAN YADAV

Most Compassionate Doctor Award

Akula Laxmi

Award for Excellence in Research

Dr Deepti Mankad

Excellence Award in Mental Health & Counselling

Dr Sujit Kumar Satpathy

Healthcare Personality of the Year

Reshma Khan

Excellence in Medical Education

Alfred Goodwin

Lifetime Achievement Award

Dr.Arunkumar H

Best Diabetes and Diabetic Foot Care Specialist

Dr Deepika Goswami

Excellence in Medical Education

Dr.Nirmal Kumar Veeraragavan

Young Medical Entrepreneur of the year

Dr. Mankads' Homeoclinic

Best Homeopathy Centre

Arogyadeep Healthcare Pvt. Ltd

Excellence award in Acupuncture & Yoga Naturopathy

Dr Meghanad Meher

Excellence Award in General Medicine

Dr. Md Imteyaj

Most Compassionate Doctor Award

Dr. S.M. Shariq

Excellence Award in Orthopedics

Ryan Varghese

Medical Innovation & Leadership Award

Dr. Santosh Swathi Lakkoju

Healthcare Icon of the Year

Pradeep Kumar

Social Work Healthcare Award

Dharmendra Kumar Parihar

Excellence Award in Rural Healthcare

Dr. Harnoor Singh Pruthi

Excellence Award in Cardiology

ANUP KUMAR MISHRA

Excellence in Hospital Quality Management

Dr. Laila Beegum

Lifetime Achievement Award

Dr. Ajil Abdulla

Healthcare Entrepreneur of the Year

Dr.DEEPAK SINGH BAJETHA

Excellence Award in Physiotherapy

Dr Jayendra Narang

Excellence Award in Neurosurgery

TNB Aesthetic Secrets

Best Cosmetic Clinic

Dr Nancy Burat

Healthcare Icon of the Year

Dr Bahar Yawazy

Healthcare Icon of the Year

Dr. Chaitanya Seshu Babu. G

Healthcare Icon of the Year

Dr Capt G. Dhanan Jaya Rao

Life time achievement Award (Veterinary Surgery)

Dr Amanur Rahman Zaka

Most Compassionate Doctor Award

Srinivas Reddy

Best Hospital Administrator of the Year

Dr. Kumaragurubaran

Healthcare Icon of the Year

Scholar Overseas

Best Overseas Job Placement for Doctors and Nurses

Dr. Ayush Garg

Excellence Award in Oncology

Dr S.N. Lokesh Kumar

Excellence Award in Orthopedics

Mohamed Qutbuddin

Healthcare Entrepreneur of the Year

Dr. Supriya Munganda

Healthcare Entrepreneur of the Year

Dr Nibedita Sahoo

Healthcare Personality of the Year

Sourav Kumar Das

Healthcare Icon of the Year

Dr. Mantri Venkataswamy

Lifetime Achievement Award

Dr. B .C CHANDRA MOULI

Excellence Award in Cardiology

SRI CHANDRA SEKARA HOSPITAL

Best Hospital – Cardiology

PHYSKRAFT Superspeciality Physiotherapy Clinic

Best Physiotherapy Clinic

Manoj Shivaji Wakhare

Social Work Healthcare Award

Asha Mahila Milk Producer Company Limited

Leading Milk Producer Company

Shwetdhara Milk Producer Company Limited

Leading Milk Producer Company

SRI CHANDRA SEKARA HOSPITAL

COVID Response Award

Dr.Arunkumar H

Young Medical Entrepreneur of the year

Shri Vishnu Shri Hospital

Best Emerging Multi-Speciality Hospital (Madhya Pradesh )

Be Well Hospitals

Best Multi-Speciality Hospital

Dr Ashwani Mudgal

Excellence Award in Orthopedics

Dr.Hemapriya Jayapal

Medical Innovation & Leadership Award

KABIR HOSPITAL

Best Hospital for Wellness & Healthcare

Dr.Kavita Sudersanadas

Excellence in Nutrition and Dietetics Education

Dr. Karuna M S

Excellence Awards in Medical Nutrition Research and Education

Dr.Lesil George

Award for Best Psychologist

Dr. Raj Deokule

Award for the Best Diabetologist

Prof Dr N. Junior Sundresh

Excellence in Medical Education

Dr. Muneeb Ahmed M K

Excellency Award in Sexual Health

Dr Pradeep Thomas

Excellence Award in Accident and Emergency (A&E)

Dr. Sneha Shamkumar Londhe

Excellence Award in Obstetrics and Gynecology

Dr Mustafa Murtuza PT

Excellence Award in Physiotherapy

Dr Anu Jacob

Healthcare Personality of the Year

Dr. Kartikeswar Jena

Young Medical Entrepreneur of the year

PM Medical Centre

Best Hospital – Diabetology

Dr T Vadivel

Excellence Award in Regenerative Medicine

Dr.ARUN KRISHNA A K

Healthcare Entrepreneur of the Year'

Dr Raviram.S

Excellence Award in Laser Proctology

Dr.E.Kalaichezhian

Best Functional Rehab Specialist

Dr. B. Kalpana Kosalram

Healthcare Icon of the Year

Dr Kiran Kumar Varma K

Healthcare Icon of the Year

Yuva Dental Clinic

Best Dental Clinic

J. Benedicta Colleen

Social Work Healthcare Award

Dr.Indumathi.K.P

Excellence Award in Public Health Dentistry

Dr Renu Kumar Watwani

Excellence Award in Physiotherapy

Dr.Swarupa Rani K

Excellence Award in Radiology

Dr. Syed Ahmed Ali

Young Medical Entrepreneur of the year

Prof. N. Balaji

Healthcare Icon of the Year

Dr Farooq Ahmed Manur

Excellence Award in Accident and Emergency (A&E)

Dr Praveen H Jain

Excellence Award in Dentistry

Dr Jeswanthmal Khatod

Healthcare Entrepreneur of the Year

Dr. Ramesh Kumar

Healthcare Icon of the Year

Kosmoderma Healthcare Pvt. Ltd

Best Cosmetic Surgery Clinic

Dr. ANNAM VENKATA AJAY KUMAR

Excellence Award in Rural Healthcare

Dr.S.Senthilkumaran

Healthcare Icon of the Year

DR.K.S.ARUN PRAKASH

Excellence Award in Forensic Medicine

Dr. P. Senthil

Excellence Award in Physiotherapy

DR. C. MOHAMMED ALI

Most Compassionate Doctor Award

Riya Sara Mathew

Excellence Award in Nursing

SUBHOJIT MUKHERJEE

Healthcare Personality of the Year

Dr. Amit Mehta

Excellence in Homeopathy

PLUS ALPHA DIAGNOSTIC AND HEALTH CARE PVT LTD

Best Diagnostic & Imaging Centre

Dr. Sunil Babu K C

Excellence Award in Ayurveda

[market-insider]

Veterinary Oncology Market Comprehensive Analysis By Top Most Players

The global veterinary oncology market size is expected to reach USD 578.0 million by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 12.1% from 2022 to 2030. Increasing prevalence of cancer in pets and demand for veterinary diagnostics are projected to drive the market over the forecast period.

Adoption of canine cancer registry globally to estimate cancer incidences is another driving factor for the market growth. According to frontiers in Veterinary Science in February 2019, the Swiss Canine Cancer Registry (SCCR) was used as a data source and was compiled for future comparative studies of canine and human cancers. This database is further helpful in mitigating the incidence of malignant tumors in the human population, thereby driving the market growth.

Gain deeper insights on the market and receive your free copy with TOC now @: Veterinary Oncology Market Report

Researchers carrying out studies focused on veterinary oncology are further boosting the veterinary oncology market growth. For instance, University of Illinois in August 2017, carried out study that involves more precise detection of metastasis (spread of cancer through the body) for head and neck tumors in dogs. Moreover, the market players are also focusing on new product innovation and strategic collaborations. For instance, in 2018 AdvaVet, a subsidiary of Oasmia Pharmaceutical AB, developed XR17 technology, which is nanoparticle formulation based that makes a single Active Pharmaceutical Ingredient (API) or multiple APIs water soluble. It is a combination therapy and is also a standard treatment for a number of cancer diseases in pet animals. 

[meditech-insights]

Animal Health Market Statistics 2021 : Growth, Forecast and Competitive Analysis to 2026

Animal health is a medical disciple that focuses on the treatment of veterinary diseases, disorders, and injuries as well as their prevention, detection, and control. It covers a wide range of animal species, including the domesticated and wild, with an extensive range of conditions that affect several species. It entails providing proper care for animals through the use of vaccines, anti-infective and anti-parasitic drugs, pharmaceutical specialty products, performance technologies, and value-added programs, such as livestock data management tools.

The Global Animal Health Market is expected to grow at a rate of ~4% to reach ~$49 billion by 2026. Rising awareness regarding animal health products, increasing demand for protein-rich food including meat, milk, eggs, and fish, growing incidence of zoonotic and food-borne diseases, increasing trend of companion animal adoption, and rising investments in research and development of medications & vaccines for animal care are some of the key factors driving the global animal health market.

Modernizations in Animal Health Market

Technical advances, innovations, and emerging technologies from artificial intelligence to stem cell therapy and new generations of vaccines, have provided greater opportunities to predict, prevent, diagnose and treat animal illness more quickly, accurately, and safely. Due to the development of new medicines and vaccinations for animal health, veterinary researchers and developers continue to make strides in limiting disease spread and its impact.

Recently, a number of technical advancements have been created to enhance animal welfare, including:

In April 2022, Zoetis announced its latest innovation in diagnostics with the addition of artificial intelligence (AI) blood smear testing to its multi-purpose platform, Vetscan ImagystTM

In June 2021, Vetoquinol announced the launch of a new device called Phovia for faster skin recovery in dogs and cats

“A new wave of innovation from smart sensors that continually monitor vital signs and AI-driven prediction technologies to mRNA vaccines, feed supplemented with health-boosting ingredients, and many more scientific advances offer enormous potential for better animal health.”- President, Global Operations, Animal Health Company, United States

Explore Premium Report on Animal Health Market @ https://meditechinsights.com/animal-health-market/

Increased Pet Animals Adoption for Companionship & Communities

Pet ownership has skyrocketed across the globe. In large markets, Over 50% of households currently own a pet which rises to over 80% in nations like Brazil and Argentina. This reflects the increased recognition that pets are not only companions but offer tangible benefits to our health and happiness. Additionally, pet owners are more likely to get to know their neighbourhood than those without pets, which can lead to more community engagement and improves the quality of life and relationships. Rise in companion animal ownership is anticipated to boost the consumption of parasiticides antimicrobial & antibiotics, vaccines, feed additives, and growth promoters in the upcoming years.

Companies Implementing both Organic & Inorganic Growth Strategies to Increase their Market Share

Players operating in global animal health market are adopting both organic and inorganic growth strategies such as collaborations, acquisitions, funding, and new product launches to garner market share.

For instance,

In June 2022, Boehringer Ingelheim and CarthroniX announced that they have entered into a research collaboration to pursue small molecule therapeutics in canine oncology. The collaboration will focus on identifying new molecules to target cancers in dogs.

North America is likely to maintain its dominance in the upcoming years

Geographically speaking, North America holds a major market share of the animal health market. This can be attributed to an increasing number of pet owners in this region - more than 67% of American households own pets, increasing occurrence of zoonotic diseases, technical developments & surge in research and development activities by prominent players in this region.

Competitive Landscape Analysis of Animal Health Market

Some of the key players operating in the global animal health market include Merck Animal Health, Ceva Sante Animale, Vetoquinol S.A., Zoetis, Boehringer Ingelheim, Elanco, and IDEXX, among others.

For More Comprehensive Insights, Contact Us @ https://meditechinsights.com/contact-us/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies,  blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

Contact:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

info@meditechinsights.com

[healthcaremarketanalysis]

Global Precision Medicine Market worth $50.2 billion by 2028

Precision Medicine Market in terms of revenue was estimated to be worth $29.1 billion in 2023 and is poised to reach $50.2 billion by 2028, growing at a CAGR of 11.5 % from 2023 to 2028 according to a new report by MarketsandMarkets™. The rising number of product approvals followed by growing focus on genetic testing, a prerequisite for precision medicine therapeutics, are the factors supporting market growth.

Download an Illustrative overview:

Browse in-depth TOC on “Precision Medicine Market”

189 — Tables

50 — Figures

240 — Pages

Hospitals and Clinics subsegment accounted is the fastest growing of the precision medicine market by product & service

Among the end user, the market is segmented hospitals and clinics and home care setting. In 2022, the hospitals and clinics segment accounted for the highest growth rate of the precision medicine market by end user. Growth in this market segment can be attributed to factors such as availability of better facilities and assistance in hospitals and clinics, accessibility to advanced diagnostic tests along with precise therapeutic regime among others.

Oncology is the fastest-growing segment of the precision medicine market by applications

Among the applications, the precision medicine market is segmented into drug discovery, clinical diagnostics, soil microbiome applications, industrial applications, ecological & environmental applications, veterinary applications, and other applications. In 2023, the drug discovery segment accounted for the fastest-growing share of the usage segment of precision medicine market. Growth in this market segment can be attributed to one of the major factors which is the growing number of research activities for development of new drugs.

Europe: The second-largest region in the precision medicine market.

The European market is the second-largest precision medicine market globally, mainly due to factors such as presence of key market players in the region. Europe is considered a major hub for precision medicine players and organizations. Moreover, greater awareness among people about newly emerging area of precision medicine, especially compared to developing regions.

Request Sample Pages:

Precision Medicine Market Dynamics:

Drivers:

· Growth in genetic testing and companion diagnostics

Restraints:

· High costs of therapeutics

Opportunities:

· Growing demand for cell and gene therapies

Challenges:

· Challenges associated with adoption of precision medicine

Key Market Players:

The market for precision medicine is competitive, with key players strategizing to capture the market. Prominent players in the precision medicine market are F. Hoffmann-La Roche Ltd. (Switzerland), Novartis AG (Switzerland), Bristol Myers Squibb (US), Gilead Sciences, Inc. (US), AstraZeneca (UK), Pfizer Inc. (US), AbbVie Inc. (US), Eli Lilly and Company (US), , GlaxoSmithKline plc (UK), Sanofi (France), Johnson & Johnson (US), Merck KGaA (Germany), Amgen, Inc. (US), Takeda Pharmaceutical Company Limited (Japan) among others.

Precision Medicine Market Advantages:

· Personalized Treatment: Precision medicine tailors medical treatment and interventions to individual patients based on their genetic makeup, lifestyle, and specific health characteristics. This approach ensures that treatments are more effective, with fewer adverse effects, as they are customized to the patient’s unique needs.

· Improved Diagnostic Accuracy: Precision medicine relies on advanced diagnostic tools and genomic sequencing to identify diseases and their underlying causes with unparalleled accuracy. This leads to earlier and more precise diagnoses, enabling timely and targeted interventions.

· Enhanced Drug Development: Pharmaceutical companies benefit from precision medicine by developing drugs that target specific genetic mutations or biomarkers associated with diseases. This approach streamlines drug development, reduces the likelihood of trial failures, and accelerates the availability of innovative treatments.

· Reduced Healthcare Costs: By avoiding trial-and-error approaches to treatment and focusing on therapies that are more likely to work for a given patient, precision medicine can potentially lower healthcare costs in the long run. Fewer unnecessary treatments, hospitalizations, and adverse reactions contribute to cost savings.

· Preventative Medicine: Precision medicine also emphasizes preventive strategies by identifying individuals at higher risk for certain diseases based on their genetic predispositions and lifestyle factors. This proactive approach allows for early interventions and lifestyle modifications to reduce disease risk.

· Data-Driven Insights: The collection and analysis of extensive patient data, including genomic and clinical information, enable researchers to uncover new insights into disease mechanisms and treatment responses. This data-driven approach accelerates medical research and innovation.

· Patient Empowerment: Precision medicine empowers patients by involving them in their healthcare decisions. Patients gain a better understanding of their health risks, treatment options, and potential outcomes, leading to more informed choices and improved overall healthcare experiences.

· Tailored Therapies for Rare Diseases: Precision medicine is particularly advantageous for rare and orphan diseases, where traditional treatment options may be limited. By identifying specific genetic abnormalities associated with these conditions, researchers can develop targeted therapies that offer hope to patients who previously had few treatment options.

· Global Health Impact: Precision medicine has the potential to address global health challenges by providing tailored solutions to diseases that affect diverse populations worldwide. It can facilitate the development of region-specific treatments and healthcare strategies.

· Long-Term Healthcare Sustainability: As precision medicine advances, it contributes to the sustainability of healthcare systems by focusing resources on treatments that are most likely to be effective, reducing unnecessary healthcare expenditures, and improving overall health outcomes.

In summary, the precision medicine market holds the promise of revolutionizing healthcare by providing individualized, data-driven, and effective treatment options, ultimately benefiting patients, healthcare providers, pharmaceutical companies, and society at large.

Recent Developments:

· In February 2023, Roche received EC approval for expansion of the Hemlibra (emicizumab) European Union (EU) marketing authorization.

· In January 2022, AstraZeneca (UK) collaborated with Scorpion Therapeutics to develop and commercialize precision medicines against hard-to-target cancer proteins, with an aim to transform oncology treatment. The size of this deal accounted for USD 75 billion.

Inquiry Before Buying:

[surajmarathedb1]

Market Analysis and Growth of Global Mice Model Market

Mice model market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to reach at an estimated value of USD 2,185.59 million and grow at a CAGR of 5.88% in the above-mentioned forecast period. Growing usage of mice models in virology and infectious diseases drives the mice model market.

Market survey and Perceptions : Global Mice Model Market

Increasing implications of mouse clinical trials (MCTs) for more predictive outcomes is the vital factor escalating the market growth, also rising demand for personalized medicine, increase in the advancements of gene editing tools, increasing demand for humanized mice models, increasing physiological similarities between human and mice and rising consumption of personalized medicine in developing and developed countries are the major factors among others driving the mice model market. Moreover, rising CRISPR emerging as a powerful tool in biomedical research and increasing demand for humanized mice models will further create new opportunities for mice model market in the forecasted period of 2021-2028.

Get sample report- https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-mice-model-market

However, rising regulations and laws for the ethical use of animals in research, increasing ongoing developments of alternative methods to animal testing, increasing strict regulations and guidelines and growing opposition on mice testing by several organizations are the major factors among others which will obstruct the market growth, while growing use of rat models will further challenge the growth of mice model market in the forecast period mentioned above.

Mice Model Market Opportunity and Market Size

Mice model market is segmented on the basis of mice type, technology, application, use and end-use. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

On the basis of mice type, mice model market is segmented into inbred, outbred, knockout and hybrid.

Based on technology, the mice model market is segmented into CRISPR, microinjection, embryonic stem cell and nuclear transfer.

Based on application, the mice model market is segmented into research & development, production and quality control and academics.

Based on use, the mice model market is segmented into human and veterinary.

The mice model market is also segmented on the basis of role of end-use into companies, organizations, academic and research institutes and contract research organizations.

Access full report- https://www.databridgemarketresearch.com/reports/global-mice-model-market

Mice Model Market Share Study and Competitive Landscape

Mice model market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to mice model market.

The major players covered in the mice model market report are

THE JACKSON LABORATORY

Champions Oncolog

Charles River Laboratories

Wuxi AppTec

Oncodesign

Aragen Bioscience

Biocytogen

Bioduro

BioModels

Creative Animodel

Covance Inc.

EPO Berlin-Buch GmbH

EUROPDX.

Explora BioLabs

Hera BioLabs

Horizon discovery Ltd.

Pharmatest Services

Urospehere SAS

MAJOR TOC OF THE REPORT

Chapter One: Introduction

Chapter Two: Market Segmentation

Chapter Three: Market Overview

Chapter Four: Executive Summary

Chapter Five: Premium Insights

Chapter Six: Global Artificial Food Flavours Market by Product & Procedure type

Get TOC of the report- https://www.databridgemarketresearch.com/toc/?dbmr=global-mice-model-market

Browse related reports

Global Bladder Disorders Market

North America Bladder Disorders Market

Europe Bladder Disorders Market

Middle East and Africa Bladder Disorders Market

Global Aseptic Sampling Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and

Neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email:  Sopan.gedam@databridgemarketresearch.com

[medi-techinsights]

Global Animal Health Market is projected to grow at a decent rate of 4% to reach $49 billion by 2026

Animal health is a medical disciple that emphasizes the prevention, detection, control, and therapeutics associated with veterinary diseases, disorders, and injuries. It covers a broad spectrum of animal species, including the domesticated and wild, with an extensive range of conditions that affect several species. It involves taking care of animals with the appropriate use of vaccines, anti-infective and anti-parasitic drugs, pharmaceutical specialty products, performance technologies, and value-added programs, such as livestock data management tools.

Technological Innovations Fuels the Global Animal Health Market

Technological advancements, innovations, and emerging technologies from artificial intelligence to stem cell therapy and new generations of vaccines, have provided greater opportunities to predict, prevent, diagnose and treat animal illness more quickly, accurately, and safely. Veterinary researchers and developers continue to break new ground in reducing disease spread and its impact due to the development of new medicines and vaccinations for animal health.

“A new wave of innovation from smart sensors that continually monitor vital signs and AI-driven prediction technologies to mRNA vaccines, feed supplemented with health-boosting ingredients, and many more scientific advances offer enormous potential for better animal health.” - President, Global Operations, Animal Health Company, United States

Adoption of Pet Animals for Companionship Drives the Animal Health Market

Pet ownership has skyrocketed across the world. Over 50% of households in leading markets currently own a pet which rises to over 80% in nations like Brazil and Argentina. This reflects the increased recognition that pets are not only companions but offer several benefits to our health and happiness. Moreover, pet owners are more likely to get to know their neighborhood than those without pets, which can lead to more community engagement and improves the quality of life and relationships.

Geographic Analysis: Global Animal Health Market

From a geographic perspective, North America holds a larger market share of the animal health market. This can be attributed to a growing number of pet owners in this region - more than 67% of American households own pets, rising incidence of zoonotic diseases, technological advancements & increase in research and development activities by leading players in this region.

Competitive Landscape Analysis: Animal Health Market

Some of the leading players operating in the global animal health market are Merck Animal Health, Ceva Sante Animale, Vetoquinol S.A., Zoetis, Boehringer Ingelheim, Elanco, and IDEXX, among others.

Companies Adopting Growth Strategies to Increase their Market Share in Animal Health Market

Leading players operating in the global animal health market are adopting both organic and inorganic growth strategies such as collaborations, acquisitions, funding, and new product launches to garner higher market share.

For instance, in June 2022, Boehringer Ingelheim and CarthroniX announced that they have entered into a research collaboration to pursue small molecule therapeutics in canine oncology. The collaboration will focus on identifying new molecules to target cancers in dogs.

Get Customized Research Report on Animal Health Market @ https://meditechinsights.com/animal-health-market/